Delix Nabs 2 New Partners
Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience.
The goal is to expedite Delix's drug development pipeline.
Psycheceutical Bioscience (OTCPK: BWVI) is advancing its proprietary ketamine topical formulation into clinical studies.
The life sciences company has partnered with Australian-based contract research organization iNGENū Pty Ltd.
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Thursday.
The Dow traded down 0.61% to 33,921.27 while the NASDAQ fell 0.61% to 11,997.21. The S&P 500 also fell, dropping, 0.60% to 4,122.69.
https://www.cnbc.com/2023/02/16/msci-delays-weighting-cuts-for-two-adani-companies-cites-replicability-concerns.html
MSCI earlier this month said it will reduce the weightings of Adani Enterprises, Adani Total Gas,
EMA Marketing Authorisation Application for leniolisib changed to standard review timetable
LEIDEN, Netherlands, Feb. 16, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the
Interactive Brokers Expands Global Client Base to Taiwan
Interactive Brokers (NASDAQ:IBKR), an automated global electronic broker, announced its appointment as the primary international broker for Sinopac
During a two-day conference held in Guangzhou on Monday, China Audio-Video and Digital Publishing Association called for stricter regulations on the time and money spent by young people on video games.